Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Statistics in Medicine
|
February 12, 2026
A Novel Method for Inserting Dose Levels Mid-Trial in Early-Phase Oncology Combination Studies
Matthew George, Ian Wadsworth, Pavel Mozgunov
Statistical Methods in Medical Research
|
March 20, 2016
Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods
Ian Wadsworth, Lisa V Hampson, Thomas Jaki
JP Journal of Biostatistics
|
August 28, 2019
A DIAGNOSTIC TOOL FOR CHECKING ASSUMPTIONS OF REGRESSION MIXTURE MODELS
Ian Wadsworth, M Lee Van Horn, Thomas Jaki
Statistical Methods in Medical Research
|
February 14, 2020
Exposure-response modelling approaches for determining optimal dosing rules in children
Ian Wadsworth, Lisa V Hampson, Björn Bornkamp, et al.
Antiviral Research
|
June 16, 2022
Poloxamer 188 - quercetin formulations amplify in vitro ganciclovir antiviral activity against cytomegalovirus
Andrew Kjar, Ian Wadsworth, Elizabeth Vargis, et al.
Clinical Pharmacology in Drug Development
|
July 14, 2023
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase Inhibitor, Capivasertib, Administered to Healthy Volunteers in the Presence and Absence of the CYP3A4 Inhibitor Itraconazole
Claire Miller, Roberto Sommavilla, Simon T Barry, et al.
Paediatric Anaesthesia
|
February 25, 2021
Study to evaluate the optimal dose of remifentanil required to ensure apnea during magnetic resonance imaging of the heart under general anesthesia
Philip Arnold, Syed Sanaulla, Lisa V Hampson, et al.
CNS Drugs
|
September 15, 2016
Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation
Ian Wadsworth, Thomas Jaki, Graeme J Sills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial
Komal Jhaveri, Hope S Rugo, Javier Cortés, et al.
The Lancet. Oncology
|
August 30, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
Mafalda Oliveira, Hope S Rugo, Sacha J Howell, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Statistics in Medicine
|
February 12, 2026
A Novel Method for Inserting Dose Levels Mid-Trial in Early-Phase Oncology Combination Studies
Matthew George, Ian Wadsworth, Pavel Mozgunov
Statistical Methods in Medical Research
|
March 20, 2016
Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods
Ian Wadsworth, Lisa V Hampson, Thomas Jaki
JP Journal of Biostatistics
|
August 28, 2019
A DIAGNOSTIC TOOL FOR CHECKING ASSUMPTIONS OF REGRESSION MIXTURE MODELS
Ian Wadsworth, M Lee Van Horn, Thomas Jaki
Statistical Methods in Medical Research
|
February 14, 2020
Exposure-response modelling approaches for determining optimal dosing rules in children
Ian Wadsworth, Lisa V Hampson, Björn Bornkamp, et al.
Antiviral Research
|
June 16, 2022
Poloxamer 188 - quercetin formulations amplify in vitro ganciclovir antiviral activity against cytomegalovirus
Andrew Kjar, Ian Wadsworth, Elizabeth Vargis, et al.
Clinical Pharmacology in Drug Development
|
July 14, 2023
Pharmacokinetics of the Akt Serine/Threonine Protein Kinase Inhibitor, Capivasertib, Administered to Healthy Volunteers in the Presence and Absence of the CYP3A4 Inhibitor Itraconazole
Claire Miller, Roberto Sommavilla, Simon T Barry, et al.
Paediatric Anaesthesia
|
February 25, 2021
Study to evaluate the optimal dose of remifentanil required to ensure apnea during magnetic resonance imaging of the heart under general anesthesia
Philip Arnold, Syed Sanaulla, Lisa V Hampson, et al.
CNS Drugs
|
September 15, 2016
Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation
Ian Wadsworth, Thomas Jaki, Graeme J Sills, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2026
Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial
Komal Jhaveri, Hope S Rugo, Javier Cortés, et al.
The Lancet. Oncology
|
August 30, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive, HER2-negative advanced breast cancer (CAPItello-291): patient-reported outcomes from a phase 3, randomised, double-blind, placebo-controlled trial
Mafalda Oliveira, Hope S Rugo, Sacha J Howell, et al.
Page
of 1